Compass Therapeutics, Inc.
A clinical-stage oncology firm developing antibody therapies that engage the immune system.
CMPX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US20454B1044
- LEI:
- Country:
- United States of America
- Address:
- 80 GUEST STREET, 2135 BOSTON
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company that develops proprietary antibody-based therapeutics to treat various cancers. The company utilizes its proprietary antibody discovery engine and an in-depth understanding of the tumor microenvironment to design product candidates that engage the immune system. Its primary objective is to create transformative cancer therapies that optimize the anti-tumor response and improve patient outcomes, addressing significant unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Compass Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Compass Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Compass Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
